Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension. [electronic resource]
Producer: 20210205Description: 103-111 p. digitalISSN:- 1724-6016
- Adrenergic alpha-2 Receptor Agonists -- adverse effects
- Aged
- Aged, 80 and over
- Antihypertensive Agents -- therapeutic use
- Brimonidine Tartrate -- adverse effects
- Carbonic Anhydrase Inhibitors -- adverse effects
- Double-Blind Method
- Drug Combinations
- Female
- Glaucoma, Open-Angle -- drug therapy
- Humans
- Intraocular Pressure -- drug effects
- Latanoprost -- therapeutic use
- Male
- Middle Aged
- Ocular Hypertension -- drug therapy
- Sulfonamides -- adverse effects
- Thiazines -- adverse effects
- Tonometry, Ocular
- Travoprost -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.